ReviewTrends in pharmacological sciences2013

Prostaglandin receptor EP2 in the crosshairs of anti-inflammation, anti-cancer, and neuroprotection.

Jianxiong Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.